Cystagon, illustration of capsule form (not a photo of the actual pack)

Illustrative image.

Cystagon

Cysteamine Bitartrate

Prescription required

$1800.00

150mg · 4 × 100 capsules · 3 months supply

BrandBranded medicine· By Mylan

$600.00 per month

How long a supply?

1 month$450.00 a month
3 months$600.00 a month
6 months$525.00 a month
Supplied from Israel

Test mode: no payment is taken. View cart

Annual cost

$6750a year at this pack size

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

About Cystagon

Overview

Cystagon is a prescription capsule containing cysteamine bitartrate. The supplied FDA label is for PROCYSBI, not Cystagon, and describes its use for nephropathic cystinosis in adults and children aged 1 year and older. Cysteamine helps reduce cystine buildup inside cells by changing it into substances that can leave the cell compartments called lysosomes.

What it treats

Nephropathic cystinosis in adults and children aged 1 year and older.

Safety information

Side effects

Common side effects reported in the supplied Procysbi label include vomiting, nausea, abdominal pain, breath or skin odor, diarrhea, tiredness, rash and headache in patients aged 6 years and older previously treated with cysteamine. In children aged 1 to under 6 years starting cysteamine, common effects include vomiting, stomach and intestinal infections, diarrhea, breath odor, nausea, electrolyte imbalance and headache. Contact a doctor promptly for severe rash, skin or bone changes, or severe, persistent or worsening abdominal symptoms. Serious risks listed include Ehlers-Danlos-like syndrome affecting the skin and bones; severe skin reactions; stomach or intestinal ulcers and bleeding; fibrosing colonopathy, which involves scarring of the colon; nervous system symptoms; low white blood cell counts; raised alkaline phosphatase levels; and increased pressure inside the skull. Blood tests and monitoring may be needed to detect some of these problems. The supplied label is for Procysbi, not Cystagon, so it does not establish Cystagon-specific side-effect information.

When to call your doctor

- Seek immediate medical attention for a severe skin rash. - Seek immediate medical attention for severe stomach pain, or stomach symptoms that persist or worsen. - Contact your doctor promptly if you develop skin sores or areas of skin or bone damage.

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Before taking this medicine

The supplied FDA label is for PROCYSBI, not Cystagon. It states that people who have had a serious allergic reaction, including anaphylaxis, to penicillamine or cysteamine must not take PROCYSBI. The label calls for caution and monitoring for skin and bone lesions resembling Ehlers-Danlos syndrome, severe skin rash, stomach or intestinal ulcers or bleeding, nervous system symptoms, low white blood cell counts, raised alkaline phosphatase levels, and increased pressure inside the skull. Severe, persistent or worsening abdominal symptoms require evaluation for fibrosing colonopathy, a condition involving scarring of the colon. Severe skin rash requires treatment discontinuation; other serious findings may also require treatment changes or discontinuation by the prescriber. Breastfeeding is not recommended. A Cystagon label is needed to confirm Cystagon-specific contraindications and precautions.

Using Cystagon

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store below 25°C in a dry place, in the original pack, away from direct light and moisture. Do not keep it in a bathroom. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label PROCYSBI (CYSTEAMINE BITARTRATE) CAPSULE, DELAYED RELEASE PELLETS PROCYSBI (CYSTEAMINE BITARTRATE) GRANULE, DELAYED RELEASE [HORIZON THERAPEUTICS USA, INC.] (DailyMed, retrieved 19 September 2026).

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines